Three scientists -- Emmanuelle Charpentier, Jennifer Doudna and Feng Zhang (張鋒) -- were named the winners of the second Tang Prize in biopharmaceutical science on Sunday "for the development of CRISPR/Cas 9 as a breakthrough genome editing platform that promises to revolutionize biomedical research and disease treatment."
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares open higher
04/18/2025 09:56 AM - Society
Taiwan headline news
04/18/2025 09:51 AM - Society
Detention of 2 DPP ex-staffers in China espionage case extended
04/17/2025 09:59 PM - Politics
Ko Wen-je says he was improperly interrogated, calls for video release
04/17/2025 07:32 PM - Business
TSMC denies rumors about joint venture with Intel
04/17/2025 07:07 PM